BiotechTube
Home/Synerkine Pharma/Hans Preusting
HP

Hans Preusting

CEO

Synerkine Pharma

Therapeutic Areas

Chronic PainNeuropathic Pain

Synerkine Pharma Pipeline

DrugIndicationPhase
SK-01Complex Regional Pain Syndrome (CRPS) / Chronic PainPre-clinical
SK-02Chemotherapy-Induced Peripheral Neuropathy (CIPN)Pre-clinical

Leadership Team at Synerkine Pharma

TD
Theo Dinklo
VP, R&D
ER
Emilie Rodrigues
Director CMC Development
View full Synerkine Pharma profile